Elevance Health operates health-benefits plans and healthcare-services businesses in the United States. Its insurance operations include commercial, Medicaid, and Medicare offerings, including plans operating under Blue Cross and Blue Shield-affiliated brands in designated markets. Its Carelon businesses provide pharmacy, behavioral-health, analytics, and care-related services, linking insurance administration with healthcare delivery support.
Elevance Health Inc. (ELV) has a MarketKingdoms composite score of 64.4 (B), an B-range rating. It ranks 883rd of 1,866 covered companies, 39th of 78 in Healthcare (sector average 64.5) and 2nd of 6 in Healthcare Plans. Scores as of 2026-10-25.
Its strongest lenses are Stock selection at 78 (Healthcare average 79) and Catalyst watch at 76 (Healthcare average 74). Its weakest lenses are Expansion (growth) at 20 (sector average 50) and Quality (profitability) at 29 (sector average 50).
| Lens | Type | ELV | Healthcare average | Healthcare Plans average | Percentile in sector |
|---|---|---|---|---|---|
| Industry opportunity | Research signal | 73 | 81 | 73 | 8th |
| Stock selection | Research signal | 78 | 79 | 76 | 38th |
| KPI momentum | Research signal | 71 | 78 | 72 | 29th |
| Catalyst watch | Research signal | 76 | 74 | 72 | 64th |
| Price (valuation) | Fundamental lens | 76 | 50 | 72 | 88th |
| Expansion (growth) | Fundamental lens | 20 | 50 | 42 | 5th |
| Quality (profitability) | Fundamental lens | 29 | 50 | 27 | 18th |
| Trend (momentum) | Fundamental lens | 66 | 50 | 57 | 68th |
The most recent call analysed was held on 2026-10-21 (fiscal 2026 Q3). MarketKingdoms checks what management promised on each call against what it later delivered.
The stock's valuation gap is -5.5%: its price is below the path its market, sector and industry moves explain (undervalued versus the model path). Factor sensitivity: market beta 0.71, sector beta -0.02, industry beta 0.78; the factor model explains 48% of its moves (R²).
| Company | Composite | Grade | Valuation gap |
|---|---|---|---|
| Humana Inc. (HUM) | 64.9 | B | +7.2% |
| CVS Health Corp. (CVS) | 64.1 | B | -15.6% |
| Cigna Group (CI) | 63.3 | B- | +2.5% |
| UnitedHealth Group Inc. (UNH) | 63.3 | B- | +3.7% |
| Centene Corp. (CNC) | 62.4 | B- | -11.2% |
Elevance Health Inc. financial statements · Healthcare sector ranking · Healthcare Plans industry ranking · All covered companies
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.